Loss to follow-up in registries of rheumatic patients treated with biologics: a potential information bias in assessing pharmacovigilance and efficacy outcomesAuthorsValido A; Silva-Dinis J; Cruz-Machado AR; Gonçalves MJ; Romão VC; Saavedra MJ; Fonseca JE; Read articleThis browser does not support PDFs. Please download the PDF to view it: Download PDF.downloadSection:Original articles